A Key Special Report Lecture – Case of “Tangning Tongluo Tablets” Exempted from Phase II Clinical Trials Shared
Case of “Tangning Tongluo Tablets” Exempted from Phase II Clinical Trials Shared On November 21, 2024, the 15th special report […]
Company News
Domestic First Case! Tangning Tongluo Tablets Approved to Directly Conduct Phase III Clinical Trials
Tangning Tongluo Tablets Approved to Directly Conduct Phase III Clinical Trials On November 12, Beletalent (ZHUHAI) Pharmaceutical Co., Ltd.（hereinafter referred to as Beletalent） received
Beletalent Deepens Exchange with Portuguese-speaking Countries Traditional Medicine Seminar to Promote Innovation and Development in the Pharmaceutical Field
Beletalent Deepens Exchange with Portuguese-speaking Countries Traditional Medicine Seminar Promote Innovation and Development in the Pharmaceutical Field Recently, the
Guizhou Bailing & MACAO G-RX made a splendid appearance at the International Exhibition in Ashgabat
Guizhou Bailing & MACAO G-RX made a splendid appearance at the International Exhibition on Healthcare, Education, and Sports Opens in Ashgabat
Guizhou Bailing made a splendid appearance at the 2024 Healthy China (Hengqin) International Traditional Chinese Medicine and Health Technology Industry Expo
Achievements in the field of innovation of new Chinese medicines From September 7th to 9th, the 2024 Healthy China (Hengqin)
Yindan Xinnaotong Soft Capsules Obtained The Registration And Marketing Authorization For Traditional Chinese Medicine In Brazil
Yindan Xinnaotong Soft Capsules Obtained The Registration And Marketing Authorization For Traditional Chinese Medicine In Brazil. Recently, the overseas registration
Subsidiary Company MACAO G-RX Established
MACAO G-RX CO., LTD. On July 9, Beletalent’s subsidiary”MACAO G-RX CO., LTD.“was successfully registered in Macao, and its business scope
The First Consultation of ISAF Success
As one of the settled enterprises in the Traditional Chinese Medicine Science and Technology Industrial Park of Co-operation between Guangdong
MEETING WITH THE GUANGDONG-HONG KONG-MACAO
THE FIRST FACE TO FACE COMMUNICATION GUIDANCE MEETING WITH THE GUANGDONG-HONG KONG-MACAO GREATER BAY AREA CENTER FOR DRUG EVALUATION AND
Follow Bailing to learn more about the latest news
The company currently owns over 200,000 mu (approximately 30,000 hectares) of medicinal herb cultivation bases, with an extraction capacity of
